Table 2 Characteristics of subjects completing the study compared with those who failed to complete the study
3 weeks (n = 104) | |||
|---|---|---|---|
Characteristics | Completer (n = 94) | Non completion (n = 11) | P |
Age [years] [mean (SD)] | 64.3 (11.4) | 57.1 (8.3) | 0.043 |
Female [n (%)] | 59 (62.8%) | 3 (27.3%) | 0.047 |
BMI [mean(SD)] | 30.7 (5.3) | 31.7 (7.5) | 0.549 |
Previous injection [n (%)] | 56 (59.6%) | 4 (36.4%) | 0.199 |
Baseline Pain [mean (SD)] | 264.5 (97.1) | 275.4 (84.3) | 0.724 |
US effusion depth [mm] [mean (SD)] | 3.7 (2.3) | 3.8 (1.7) | 0.924 |
PD grade [median (IQR)] | 0 (0,1) | 0 (0,1) | 0.702 |
Osteophyte grade [median (IQR)] | 2 (1,3) | 2 (1,3) | 0.977 |
JSN grade [median (IQR)] | 2 (1,2) | 2 (1,2) | 0.538 |
hsCRP [mg/L] [median (IQR)] | 5.58 (1.5,6.5) | 7.80 (3.8, 10.1) | 0.021 |
Positive US arthrogram [n (%)] | 66 (70.2%) | 8 (72.7%) | 1.00 |
Responder at 3 weeks [n (%)] | 56 (60.2) | 7 (63.6) | 1.00 |